Compare Illumina, Inc. (ILMN) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Motorola Solutions Inc — how do they compare? Illumina, Inc. trades at $278.17 (market cap $39.95B), while Motorola Solutions Inc trades at $444.18 (market cap $74.00B). The key difference: Motorola Solutions Inc is the larger of the two by market cap, and Motorola Solutions Inc pays a 1.08% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Motorola Solutions Inc for 100 Days on average.
| ILMN | MSI | |
|---|---|---|
Market Cap | $39.95B | $74.00B |
Volume | 3,169,503 | 722,147 |
Sector | Health | Technology |
52-Week High | $293.69 | $491.24 |
52-Week Low | $91.00 | $363.83 |
Typical Hold Time | 83 Days | 100 Days |
Enterprise Value | $41.31B | $82.90B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ILMN trades at $264.40, down 1.25% on the day, but remains near its recent 52-week high of $278.99 (Defense World, 2026-10-01). The stock has surged 94.9% year-to-date (Zacks Investment Research, 2026-09-24), supported by strong earnings beats in recent quarters and a bullish technical trend. Fundamentals show a significant turnaround, with 2025 net income reaching $850 million after prior losses, though valuation ratios like a P/E of 49.36 are elevated. The pending inclusion in the S&P 500 (PRNewsWire, 2026-09-04) adds a positive catalyst.
The outlook is positive, driven by sequencing growth, AI integration in genomics, and improved profitability. However, risks include high valuation sensitivity, cost volatility, and competitive pressures in the life sciences sector. Analyst consensus is bullish with a 54% buy rating, but the average price target of $241 suggests limited near-term upside from current levels.
MSI (Motorola Solutions) trades at $447.12, down 0.3% on the day, with a bearish technical signal but strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.41 surpassing the $3.85 estimate. Revenue grew to $11.68B in 2025, and net income margin improved to 17.44%. Recent news highlights expansion in defense and public safety contracts, including a $139 million Louisiana deal and a $1.5B acquisition of D-Fend Solutions.
Outlook remains positive driven by a record $15.6B backlog and strategic acquisitions, though high valuation ratios (P/E 35.23) and significant investing cash outflows pose risks. Analyst consensus is bullish with a $525.86 price target, implying 17.6% upside, but investors should monitor debt levels and integration of recent purchases.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
